Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

PP405 is a potential hair loss treatment showing promising early results, with hopes for market release by 2028, but skepticism remains due to inconclusive data and past disappointments with similar products. Current treatments like Minoxidil and Finasteride have side effects, leading some to anticipate PP405 as a safer alternative, though its effectiveness compared to placebo is debated.

Increased hair shedding after starting Dutasteride is normal and indicates treatment efficacy, as it triggers a synchronized shedding phase to make way for stronger hair growth. It is advised to continue with the current treatment plan and assess results in 9 to 12 months.

A 21-year-old has been using oral finasteride, topical minoxidil, and tretinoin for 2 months and notices potential regrowth with baby hairs. They consider adding dutasteride weekly but wonder if current treatments are sufficient.

A 21-year-old is experiencing aggressive hair loss despite using minoxidil, dutasteride, and GFC, and is seeking advice on whether to switch treatments or consider a hair transplant. Suggestions include continuing current treatments, checking for underlying health issues, and considering alternatives like RU58841 or microneedling.

A user has been using 1mg oral finasteride and 5% topical minoxidil for six months, with some derma stamping, but feels hair growth has stagnated and is considering PRP or a hair transplant. Others advise continuing the current regimen, noting that maintaining existing hair is an achievement, and suggest ignoring negative comments from friends.

The user saw no hair regrowth after a year of using finasteride and dutasteride, only maintaining their current hair. Many recommend adding minoxidil for potential regrowth.

Chinese researchers have successfully created hair follicles in vitro, potentially offering unlimited hair for transplantation and a cure for hair loss. They plan to test these follicles in vivo on human scalps.

Hair cloning for hair loss is unlikely to be available or affordable in the next 10 years. Current treatments like Minoxidil, finasteride, and RU58841 are still the main options, with skepticism about new advancements.

The user has been using topical minoxidil and oral finasteride for hair regrowth, noticing some improvement and baby hairs at the hairline after four months. Suggestions include continuing the current treatment, considering microneedling, ketoconazole shampoo, vitamins, and possibly RU58841, while avoiding a hair transplant.

A 26-year-old male experienced hair thinning since age 18 and tried various treatments, including topical minoxidil, oral finasteride, and a hair transplant. He is currently using topical finasteride, minoxidil, tretinoin, hydrocortisone, and oral dutasteride, and is satisfied with the results 6.5 months post-transplant.

The user is considering alternatives to topical minoxidil for hair growth due to concerns about future cat ownership, mentioning stemoxydine and redensyl as possibilities. They currently use topical regaine foam and oral finasteride.

People are excited about a new hair loss treatment, PP405, and some suggest using Twitter to increase its visibility. Current treatments mentioned include finasteride, minoxidil, and dutasteride, but skepticism remains about the effectiveness of new treatments.

The conversation discusses skepticism about new hair loss treatments, with many users expressing doubt about the effectiveness and availability of future solutions. Current treatments like minoxidil, finasteride, and hair transplants are mentioned as reliable options.

A 22-year-old shared their hair loss journey, starting with homeopathic treatments and later using Minoxidil and Finasteride, seeing some regrowth. They are currently on oral Finasteride, PRP treatments, and saw palmetto serum, considering reintroducing Minoxidil or switching to Dutasteride for better results.

Pelage Pharmaceuticals is developing PP405, a topical treatment for hair growth, currently in Phase 2a trials. There is skepticism about the company's claims, and no fast-tracking approval timeline has been detailed.

The conversation is about managing hair loss while on hormone replacement therapy (HRT) with estrogen and spironolactone. The user considers adding finasteride but decides to wait and see the effects of the current treatment.

PP405 is a new drug in Phase 2 trials for hair loss, generating cautious optimism among users. Some users are currently using finasteride and experiencing side effects, while others are skeptical about unapproved products being sold.

The user has been using oral Minoxidil and Finasteride for hair loss, with some noticing slight regrowth, particularly baby hairs, but overall progress is unclear. Suggestions include continuing the current treatment, considering a hair transplant, or trying additional therapies like topical treatments or laser therapy.

The user has been using oral finasteride, minoxidil, and supplements for six months with some progress in hair loss treatment. They are considering a hair transplant and have been advised to continue the current regimen for 12-18 months, possibly adding microneedling or trying dutasteride.

After 8 months on finasteride, the user experiences increased hair shedding and thinning, despite also using minoxidil and microneedling. They consider switching to dutasteride but decide to continue the current regimen for a year before reassessing.

OP has been using a premixed topical solution of 5% minoxidil and 0.025% tretinoin for 6 months with good results and is unsure if shaking the bottle is necessary. OP is also using Dutasteride and is curious about the impact of shaking on treatment effectiveness.

Blocking DHT is not a complete solution for hair loss; instead, altering the scalp's response to DHT may be more effective. Topical finasteride and minoxidil are current treatments, but future approaches may involve bioengineering, gene therapy, and inflammation control.

The user is experiencing increased thinning around the crown after starting topical Minoxidil and is considering switching from Finasteride to Dutasteride. Responses suggest the thinning might be a temporary shedding phase due to the new treatment, and it's advised to continue the current regimen and monitor progress.

The user is questioning if their hair is regrowing and considering adding tretinoin to their regimen, which includes minoxidil. They are concerned about male pattern baldness and comparing their current hairline to past photos.

The conversation discusses the need for a localized 5-alpha reductase inhibitor that only affects the scalp without systemic side effects, similar to pyrilutamide's approach. Current treatments like topical liposomal finasteride and dutasteride are mentioned, but concerns about their systemic effects and lack of research are highlighted.

PP405 is a promising new treatment for hair loss that activates dormant stem cells in hair follicles, potentially bypassing the effects of DHT. It is currently in phase 2 trials and could be available between 2027 and 2030, but it is not considered a definitive cure.

New hair loss treatments like PP-405, AMP-303, and SCUBE3 are being discussed, but none are confirmed to fully restore hairlines. Current treatments like Minoxidil, Finasteride, and RU58841 are still widely used, with some hope for future advancements in hair regrowth.

Catalase is discussed as a potential treatment for delaying or reversing grey hair, but no reliable medicine currently exists. Other mentioned treatments include Imatinib, senolytics like Quercetin and Fisetin, He Shou Wu, Argan oil, and reishi mushroom extract, though their effectiveness varies.

A user shared their one-year hair loss treatment progress using oral finasteride, topical finasteride/minoxidil, and microneedling, reporting no current side effects and significant hair improvement. They also use Head & Shoulders for dandruff control and recommend consistency in treatment.

The user is experiencing hair thinning and has a vitamin D deficiency, which they suspect might be causing the issue, but they are also considering androgenic alopecia (AGA) as a cause. They are currently using minoxidil and are unable to get finasteride prescribed, while others suggest addressing the vitamin D deficiency and consulting a dermatologist.